LIVER-SPECIFIC DELETION OF LIPID PHOSPHATE PHOSPHATASE 3 EXACERBATES ATHEROSCLEROSIS IN APOE-KO MICE

被引：0
|
作者：
Manzini, S. [1 ]
Busnelli, M. [1 ]
Ganzetti, G. S. [1 ]
Parolini, C. [1 ]
Dellera, F. [1 ]
Sirtori, C. R. [1 ]
Laaksonen, R. [2 ]
Chiesa, G. [1 ]
机构：
[1] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy
[2] Oy Zora Biosci, Espoo, Finland
来源：
ATHEROSCLEROSIS | 2014年 / 235卷 / 02期
关键词：
D O I：
10.1016/j.atherosclerosis.2014.05.060
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS-0740
引用
收藏
页码：E31 / E31
页数：1
相关论文
共 50 条
  • [21] Liver-specific deletion of augmenter of liver regeneration (ALR) induces accelerated steatohepatitis in mice
    Gandhi, Chandrashekhar R.
    Chaillet, J. Richard
    Nalesnik, Michael A.
    Kumar, Sudhir
    Dangi, Anil
    Ferrell, Robert
    Wu, Tong
    Devanovic, Senad
    Stolz, Donna B.
    Wang, Jiang
    Starzl, Thomas
    HEPATOLOGY, 2014, 60 : 736A - 736A
  • [22] FENRETINIDE TREATMENT IN APOE-KO MICE SEVERELY ALTERS ERYTHROCYTE TURNOVER AND CAUSES A DRAMATIC INCREASE OF CIRCULATING LEUKOCYTES RESULTING IN A WORSENED ATHEROSCLEROSIS DEVELOPMENT
    Busnelli, M.
    Manzini, S.
    Bonacina, F.
    Colombo, A.
    Soldati, S.
    Barbieri, S. S.
    Amadio, P.
    Sandrini, L.
    Arnaboldi, F.
    Donetti, E.
    Laaksonen, R.
    Paltrinieri, S.
    Scanziani, E.
    Chiesa, G.
    ATHEROSCLEROSIS, 2020, 315 : E56 - E56
  • [23] PREVENTION OF ATHEROSCLEROSIS AND HEPATIC STEATOSIS BY COMBINED, LIVER-SPECIFIC DELETION OF GPR146 AND ANGPTL3
    Mathada, U. Tharehalli
    Rimbert, A.
    Zhang, B.
    Kloosterhuis, N.
    Huijkman, N.
    Smit, M.
    Gerding, A.
    De Sluis, B. Van
    Kuivenhoven, J. A.
    ATHEROSCLEROSIS, 2023, 379
  • [24] The effects of cell type specific iNOS deletion on atherosclerosis development in apoE knockout mice
    Kuhlencordt, PJ
    Chen, JQ
    Han, F
    Astern, J
    Riehl, G
    Sykes, M
    Ertl, G
    Huang, PL
    CIRCULATION, 2003, 108 (17) : 39 - 39
  • [25] Liver-Specific Deletion of Augmenter of Liver Regeneration Accelerates Development of Steatohepatitis and Hepatocellular Carcinoma in Mice
    Gandhi, Chandrashekhar R.
    Chaillet, J. Richard
    Nalesnik, Michael A.
    Kumar, Sudhir
    Dangi, Anil
    Demetris, A. Jake
    Ferrell, Robert
    Wu, Tong
    Divanovic, Senad
    Stankeiwicz, Traci
    Shaffer, Benjamin
    Stolz, Donna B.
    Harvey, Stephen A. K.
    Wang, Jiang
    Starzl, Thomas E.
    GASTROENTEROLOGY, 2015, 148 (02) : 379 - U176
  • [26] POTENTIAL ROLE OF LIPID PHOSPHATE PHOSPHATASE (LPP3) IN ATHEROSCLEROSIS
    Touat, Z.
    Blum, Y.
    Weidmann, H.
    Proust, C.
    Durand, H.
    Ianacci, F.
    Karabina, A. S.
    Cievelek, M.
    Cambien, C.
    Lusis, A. J.
    Ninio, E.
    ATHEROSCLEROSIS, 2015, 241 (01) : E36 - E36
  • [27] Myeloid-specific Deletion in Lipid Phosphate Phosphatase3 (plpp3) Increases Cardiac Inflammation
    Tripathi, Himi
    Shindo, Kazuhiro
    Donahue, Renee
    Gao, Erhe
    Morris, Andrew J.
    Smyth, Susan S.
    Abdel-latif, Ahmed
    CIRCULATION, 2020, 142
  • [28] Inducible liver-specific knockdown of protein tyrosine phosphatase 1B improves glucose and lipid homeostasis in adult mice
    C. Owen
    E. K. Lees
    L. Grant
    D. J. Zimmer
    N. Mody
    K. K. Bence
    M. Delibegović
    Diabetologia, 2013, 56 : 2286 - 2296
  • [29] Impaired lipid metabolism in liver-specific phosphoenolpyruvate carboxykinase (PEPCK) knockout mice
    She, PX
    Shelton, KD
    Magnuson, MA
    DIABETES, 2000, 49 : A6 - A6
  • [30] Liver-specific deletion of the transferrin receptor 2 gene in mice leads to iron overload
    Subramaniam, V. N.
    Summerville, L.
    Wallace, D. F.
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (06) : 534 - 534
12345